{
    "clinical_study": {
        "@rank": "97397", 
        "acronym": "AEFI", 
        "arm_group": {
            "arm_group_label": "sending message", 
            "arm_group_type": "Experimental", 
            "description": "The investigators would send the tip to the children's guardian"
        }, 
        "brief_summary": {
            "textblock": "The investigators would remind the guardians of observation after immunization via sending\n      short message and collect the information of AEFI by two ways, short message/telephone and\n      website questionnaire."
        }, 
        "brief_title": "Explore Active Surveillance Mode of the Community's Adverse Event Following Immunization(AEFI)", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Adverse Reaction to Drug", 
        "condition_browse": {
            "mesh_term": "Drug Toxicity"
        }, 
        "detailed_description": {
            "textblock": "The investigators will compare the rate between active and inactive surveillance of AEFI"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  According with the regular vaccination\n\n          -  Immunization the acellular pertussis diphtheria tetanus vaccine and Measles and\n             rubella combined vaccine\n\n        Exclusion Criteria:\n\n          -  Disapproval the AEFI information"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "1000", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01830257", 
            "org_study_id": "BJCDPC-7"
        }, 
        "intervention": {
            "arm_group_label": "sending message", 
            "description": "Sending the suggestive short message", 
            "intervention_name": "sending message", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 11, 2013", 
        "number_of_arms": "1", 
        "official_title": "Phase 4 Study of MR and APDT Vaccine", 
        "overall_official": {
            "affiliation": "Beijing Chaoyang District Centers for Disease Control and Prevention", 
            "last_name": "Zhaoyun Wang, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Incidence about AEFI comes from the rate between number of adverse event and the all quantity for immunization about MR and APDT", 
            "measure": "Incidence about AEFI", 
            "safety_issue": "Yes", 
            "time_frame": "1.5years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01830257"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Beijing Center for Disease Control and Prevention", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Beijing Center for Disease Control and Prevention", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}